Drug hypersensitivity syndrome caused by minocycline

Journal of Cutaneous Medicine and Surgery

Volumn 10, Issue 3, 2006, Pages 131-135

  Tsuruta, Daisuke ^a   Someda, Yukiko ^a   Sowa, Junko ^a   Kobayashi, Hiromi ^a   Ishii, Masamitsu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; PREDNISOLONE; ANTIINFECTIVE AGENT;

ACNE; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EOSINOPHILIA; FEMALE; FEVER; HUMAN; LIVER FUNCTION TEST; LYMPHOCYTOSIS; MEDICAL EXAMINATION; PRIORITY JOURNAL; SIDE EFFECT; SKIN DEFECT; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; ACNE VULGARIS;

ACNE VULGARIS; ADULT; ANTI-BACTERIAL AGENTS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MINOCYCLINE;

EID: 35748974871     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2006.00019     Document Type: Article

References (25)

1. Maibach H. Second-generation tetracyclines, a dermatologic overview: clinical uses and pharmacology. Cutis 1991;48:411-7.
2. Meynadier J, Alirezai M. Systemic antibiotics for acne. Dermatology 1998;196:135-9.
3. MacNeil M, Haase DA, Tremaine R, et al. Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse cutaneous reaction to minocycline. J Am Acad Dermatol 1997;36:347-50.
4. Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature. Arch Dermatol 1996;132:934-9.
5. Kaufmann D, Pichler W, Beer JH. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne. Arch Intern Med 1994;154:1983-4.
6. Piette AM, Ramanoelina J, Gepner P, et al. Systemic reaction induced by minocycline treatment: a report of four patients and a review of the literature. Rev Med Intern 1999;20:869-74.
7. Disdier P, Granel B, Serratrice J, et al. A teenager with rash and fever. Lancet 2001;358:2046.
8. Lupton JR, Figueroa P, Tamjidi P, et al. An infectious mononucleosis-like syndrome induced by minocycline: a third pattern of adverse drug reaction. Cutis 1999;64:91-6.
9. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001;137:357-64.
10. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988;82:1826-32.
11. Callot V, Roujeau JC, Bagot M, et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol 1996;132:1315-21.
12. Shapiro LE, Shear NH. Mechanisms of drug reactions: the metabolic track. Semin Cutan Med Surg 1996;15:217-27.
13. Schlienger RG, Knowles SR, Shear NH. Lamotrigine-associated anticonvulsant hypersensitivity syndrome. Neurology 1998;51:1172-5.
14. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85.
15. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 1996;15:250-7.
16. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005;209:123-9.
17. Suzuki Y, Inagi R, Aono T, et al. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998;134:1108-12.
18. Tohyama M, Yahata Y, Yasukawa M, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpes virus 6. Arch Dermatol 1998;134:1113-7.
19. Masaki T, Fukunaga A, Tohyama M, et al. Human herpes virus 6 encephalitis in allopurinol-induced hypersensitivity syndrome. Acta Derm Venereol 2003;83:128-31.
20. Tohyama M, Hashimoto K. Hypersensitivity syndrome and HHV-6. Nippon Rinsho 2001;59:2285-92.
21. Gleichmann H. Studies of the mechanism of drug sensitization: T-cell dependent popliteal lymph node reaction to diphenylhydantoin. Clin Immunol Immunopathol 1981;18:203-11.
22. Yawalkar N, Shrikhande M, Hari Y, et al. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol 2000;106:1171-6.
23. Aihara M, Sugita Y, Takahashi S, et al. Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br J Dermatol 2001;144:1231-4.
24. Steeper TA, Horwitz CA, Ablashi DV, et al. The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illness not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol 1990;93:776-83.
25. Renn CN, Straff W, Dorfmuller A, et al. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Dermatol 2002;147:1166-70.